gene sequencing
-
Invitae’s First of Its Kind Cancer Test Receives FDA Marketing Authorization
The FDA awarded marketing authorization for a new Invitae test that uses next-generation sequencing to assess multiple genes to identify variants indicating a person’s predisposition for certain cancers. The regulatory action creates a new regulatory classification making Invitae’s test the predicate device for future cancer tests.
-
How Genome Sequencing Can Broaden the Scope of Newborn Screening
Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Morning Read: Former Google X Senior VP now CEO of Grail, cancer detection gene sequencing firm
Also, CTI BioPharma Corp said the U.S Food and Drug Administration has put a full clinical hold on the company’s investigational new drug application for pacritinib.
-
Morning Read: RainDance Technologies withdraws $60M IPO, omega-3 might not actually help cognition
Gene sequencing firm RainDance Technologies has withdrawn its $60M IPO, and researchers have found that omega-3 supplements might not have any affect on cognition for older people.
-
Good news for genomics startups: Illumina & Yuri Milner jump into the accelerator game
Next-generation sequencing has reached the “lift-off stage,” according to Yuri Milner. He’s not just saying […]